312-422-1111 [email protected]
  • Stay Updated
  • Become a Member
  • Business Solutions
  • Contact Us
iBIO
  • About
    • Who We Are
    • Leadership
    • Contact
  • PROGRAMS
    • Events Calendar
    • Annual iCON Awards
    • Policy & Advocacy
      • Advocacy Center
      • Advocacy Toolkit
      • Rare Disease
    • Business Solutions
    • STEMgirls Camp – Chicago
    • LabShare
    • STEMKits
    • StellarGirls
    • BioGENEius Illinois
  • Membership
    • Member Benefits
    • Join iBIO
  • Resources
    • News
    • Member Committees
    • Daily Newsletter
    • IBIO Reports
      • About Illinois
      • Investment Report
      • State Incentives
Select Page
Tempus IPO Highlights Medtech Industry Resilience Amid Shifting VC Landscape

Tempus IPO Highlights Medtech Industry Resilience Amid Shifting VC Landscape

by John Conrad | Aug 20, 2024 | NewsBrief

According to PitchBook’s latest Emerging Tech Research report on the medtech industry, the sector is showing resilience and growth despite recent market challenges. The report highlights the successful IPO of precision medicine company Tempus in June 2024 as a...
  • Home
  • About Us
  • Business Solutions
  • Advocacy
  • News
  • Join iBIO
  • Contact Us
  • Facebook
  • X
  • RSS
© 2022 iBIO | All Rights Reserved | Powered by BIRKEY.COM
X